Advertisement
Screener

Evolutionary Genomics, Inc. Cost-method Investments, Realized Gains

Evolutionary Genomics, Inc. Cost-method Investments, Realized Gains

Evolutionary Genomics, Inc. reported Cost-method Investments, Realized Gains of $69.22 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-05.

Discontinued › Income Statement › Other Income

us-gaap:CostMethodInvestmentsRealizedGains · last filed 2018-03-05

  • Evolutionary Genomics, Inc. cost-method investments, realized gains for fiscal 2016 was $69.22K, a 1438.27% increase from fiscal 2015.
  • Evolutionary Genomics, Inc. cost-method investments, realized gains for fiscal 2015 was $4.50K.
Period endCost-method Investments, Realized Gains 12 month
2016-12-31$69.22K
10-K · filed 2018-03-05
2015-12-31$4.50K
10-K · filed 2017-02-10